首页> 外文期刊>BMC Women s Health >Evaluating DREAMS HIV prevention interventions targeting adolescent girls and young women in high HIV prevalence districts in South Africa: protocol for a cross-sectional study
【24h】

Evaluating DREAMS HIV prevention interventions targeting adolescent girls and young women in high HIV prevalence districts in South Africa: protocol for a cross-sectional study

机译:评估梦想艾滋病毒预防干预措施,瞄准南非高艾滋病毒流行区的青春期女孩和幼年:横断面研究的议定书

获取原文
           

摘要

Young women in sub-Saharan Africa remain at the epicentre of the HIV epidemic, with surveillance data indicating persistent high levels of HIV incidence. In South Africa, adolescent girls and young women (AGYW) account for a quarter of all new HIV infections. Determined, Resilient, Empowered, AIDS-free, Mentored and Safe (DREAMS) is a strategy introduced by the United States President’s Emergency Plan for AIDS Relief (PEPFAR) aimed at reducing HIV incidence among AGYW in 10 countries in sub-Saharan Africa by 25% in the programme’s first year, and by 40% in the second year. This study will assess the change in HIV incidence and reduction in risk associated behaviours that can be attributed to the DREAMS initiative in South Africa, using a population-based cross-sectional survey. Data will be collected from a household-based representative sample of AGYW (between the ages 12–24?years) in four high prevalence districts (more than 10% of the population have HIV in these districts) in South Africa in which DREAMS has been implemented. A stratified cluster-based sampling approach will be used to select eligible participants for a cross-sectional survey with 18,500, to be conducted over 2017/2018. A questionnaire will be administered containing questions on sexual risk behaviour, selected academic and developmental milestones, prevalence of gender based violence, whilst examining exposure to DREAMS programmes. Biological samples, including two micro-containers of blood and self-collected vulvovaginal swab samples, are collected in each survey to test for HIV infection, HIV incidence, sexually transmitted infections (STIs) and pregnancy. This study will measure trends in population level HIV incidence using the Limiting antigen (LAg) Avidity Enzyme Immuno-Assay (EIA) and monitor changes in HIV incidence. Ending the HIV/AIDS pandemic by 2030 requires the continual monitoring and evaluation of prevention programmes, with the aim of optimising efforts and ensuring the achievement of epidemic control. This study will determine the impact DREAMS interventions have had on HIV incidence among AGYW in a ‘real world, non-trial setting’.
机译:撒哈拉以南非洲的少妇留在艾滋病病毒疫情的震中,监测数据表明持续高水平的艾滋病毒发生入侵。在南非,青少年女孩和年轻女性(Agyw)占所有新的艾滋病毒感染的四分之一。坚定不移,赋权,无艾滋病,辅导和安全(梦想)是美国总统援助救济(百氟铝)引入的策略,旨在减少艾哈拉非洲的10个国家的艾滋病毒发生入狱率为25在该计划的第一年的百分比,第二年达到40%。本研究将评估艾滋病毒发生病率的变化和减少风险相关行为的风险,这些行为可以归因于南非的梦想倡议,利用基于人口的横断面调查。在南非的四个高普遍地区(超过12-24岁之间的年龄在12-24岁之间)的基于家庭代表性样本(12-24岁之间)的数据将收集到南非的南非(超过10%的人口)实施的。基于分层的基于集群的取样方法将用于选择符合条件的参与者,以获得18,500人的横断面调查,以在2017/2018年进行。将对有关性风险行为,选定的学术和发展里程碑,性别暴力普遍存在的问题进行调查问卷,同时检查梦想计划。在每个调查中收集了生物样品,包括两种微容器的血液和自集的外阴拭子样品,以测试HIV感染,艾滋病毒发病率,性传播感染(STIS)和怀孕。本研究将使用限制抗原(滞后)亲密酶免疫测定(EIA)测量人口水平HIV发病率的趋势,并监测HIV发病率的变化。结束艾滋病毒/艾滋病大流行于2030年需要持续监测和评估预防计划,目的是优化努力和确保实现疫情控制的目标。本研究将决定梦想干预措施在“现实世界,非审判环境”中享受艾滋病毒发生的干预措施。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号